Home > Analytics > INDOCO REMEDIES

INDOCO REMEDIES
Intrinsic Value | Fundamental Analysis

BOM : 532612     NSE : INDOCO    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued]
Debt : Average
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Sep 30,2022
Price(EOD): ₹ 327.10
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 3,015.86 Cr
Value of ₹ 1 Lac invested in INDOCO REMEDIES
on Oct 03,2017 (price: ₹ 206.40)

₹ 1 L

₹ 1.58 L

1W : -1.7% 1M : -8.5% 1Y : -27.1%
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results
Industry Peers & Returns1W1M1Y
INDOCO REMEDIES -1.7% -8.5% -27.1%
SUN PHARMACEUTICAL INDUSTRIES 5.8% 8.9% 19.4%
DIVIS LABORATORIES 0.4% 2.4% -27.6%
DR REDDYS LABORATORIES 4.9% 3.1% -9.1%
CIPLA 4.7% 9% 14.9%
GLAND PHARMA 1.5% -16.4% -43.2%
PIRAMAL ENTERPRISES -2.9% -16% -68.6%
CADILA HEALTHCARE 8.6% 3.8% -29.6%
TORRENT PHARMACEUTICALS 3% 1.5% -0.4%

FUNDAMENTAL ANALYSIS OF INDOCO REMEDIES

 
Fundamentals Score
[ Q(TTM): Jun2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF INDOCO REMEDIES

 
Valuation Score
[As on : Sep 30,2022 ]

Ratio Consolidated
P/E
P/B
P/S
19.61
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 153.70 Cr
[Latest Qtr - Jun2022 - Consolidated Results ]

3.33
P/B Calculated based on Book Value of Rs 904.64 Cr
[Latest Year - Mar2022 - Consolidated Results ]

1.93
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 1,562.22 Cr
[Latest Qtr - Jun2022 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 17% undervalued companies ! Discover More →

FAIR VALUE OF INDOCO REMEDIES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
54%
18%
14%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF INDOCO REMEDIES



INDOCO REMEDIES vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF INDOCO REMEDIES

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.27
0.34
0.38
0.33
0.27
0.34
0.39
0.33
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF INDOCO REMEDIES

Pledged Promoter Shares
0 %
As on : Jun2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF INDOCO REMEDIES

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-0.22%
-11.29%
-19.08%
-4.65%
5.55%
-17.78%
-21.11%
-2.75%
QtrlyTrend
-6
Latest Qtr: Jun2022
Quarterly Result Analysis →


INDOCO REMEDIES related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE 1.8% 1.4% -9.9%
S&P BSE 250 SMALLCAP -1% -0.6% -0.2%
S&P BSE 400 MIDSMALLCAP -1.2% -1.4% 0.8%
S&P BSE SMALL CAP -1.3% -0.7% 1.7%
S&P BSE MIDSMALLCAP -1.5% -1.4% 0.2%
NSE Indices1W1M1Y
NIFTY SMALLCAP250 -1.2% -0.9% -1.3%
NIFTY MID SMALL400 -1.3% -1.5% 1.9%
NIFTY500 MULTICAP 50:25:25 -1.4% -2.5% -1.2%
NIFTY 500 -1.5% -3.2% -2.4%

You may also like the below Video Courses


FAQ about INDOCO REMEDIES


Is INDOCO REMEDIES good for long term investment?

As on Sep 30,2022, the Fundamentals of INDOCO REMEDIES look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of INDOCO REMEDIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is INDOCO REMEDIES UnderValued or OverValued?

As on Sep 30,2022, INDOCO REMEDIES is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!

What is the Intrinsic Value of INDOCO REMEDIES ?

As on Sep 30,2022, the Intrinsic Value of INDOCO REMEDIES is Rs. 276.13 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 212.13
Fair Value [Median EV / Sales Model] : Rs. 276.13
Fair Value [Median Price / Sales Model] : Rs. 288.04
Estimated Median Fair Value of INDOCO REMEDIES : Rs. 276.13

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is INDOCO REMEDIES trading at a Premium or Discount?

As on Sep 30,2022, INDOCO REMEDIES is trading at a Premium of 18% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].